These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24295825)

  • 1. Raw data from clinical trials: within reach?
    Doshi P; Goodman SN; Ioannidis JP
    Trends Pharmacol Sci; 2013 Dec; 34(12):645-7. PubMed ID: 24295825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 4. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can non-randomized trials be considered to be equivalent to randomized trials in forensic mental health?
    Leese M
    Crim Behav Ment Health; 2005; 15(2):121-2. PubMed ID: 16470506
    [No Abstract]   [Full Text] [Related]  

  • 7. ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement?
    Ozdemir V; Joly Y; Knoppers BM
    Am J Bioeth; 2011 Mar; 11(3):11-3. PubMed ID: 21400375
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical research: access to raw data is necessary.
    Prescrire Int; 2013 Jan; 22(134):4. PubMed ID: 23367673
    [No Abstract]   [Full Text] [Related]  

  • 9. Data handling in clinical trials: an ongoing debate.
    Jongen PJ
    Mult Scler; 1995; 1 Suppl 1():S60-3. PubMed ID: 9345402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 11. Rank minimization with a two-step analysis should not replace randomization in clinical trials.
    Morris T
    J Clin Epidemiol; 2012 Jul; 65(7):810-1. PubMed ID: 22564502
    [No Abstract]   [Full Text] [Related]  

  • 12. Q&A: Rajeshwari Sridhara, Robert Temple on trial design. Interviewed by Suzanne Rose.
    Sridhara R; Temple R
    Cancer Discov; 2013 Mar; 3(3):245. PubMed ID: 23475863
    [No Abstract]   [Full Text] [Related]  

  • 13. The necessity of placebo application in psychotropic drug trials.
    Benkert O; Maier W
    Pharmacopsychiatry; 1990 Sep; 23(5):203-5. PubMed ID: 2251299
    [No Abstract]   [Full Text] [Related]  

  • 14. Are these data real? Statistical methods for the detection of data fabrication in clinical trials.
    Al-Marzouki S; Evans S; Marshall T; Roberts I
    BMJ; 2005 Jul; 331(7511):267-70. PubMed ID: 16052019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to share results of clinical trials with study participants?].
    Sarradon-Eck A; Mancini J; Genre D; Sakoyan J; Desclaux A; Julian-Reynier C
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():33-6. PubMed ID: 22494655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 18. CONSORT 2010.
    Chen YL; Yang KH
    Lancet; 2010 Jul; 376(9737):230. PubMed ID: 20656116
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, operation, and interpretation of clinical trials.
    Pihlstrom BL; Barnett ML
    J Dent Res; 2010 Aug; 89(8):759-72. PubMed ID: 20581353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing risk and improving efficacy of clinical trials: the adaptive design.
    Dangi-Garimella S
    Am J Manag Care; 2014 Aug; 20(11 Spec No.):E8. PubMed ID: 25618150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.